Summary of Classification and Labelling
Notified classification and labelling
General Information
473-160-6 |
Formula 1a:Trisodium {1-(2-carboxylato-kO-5-sulfonatophenyl)-5-[3-(2,6-difluoropyrimidin-4-ylamino)-2-olato-kO-5-sulfonatophenyl]-3-phenylformazan-5-ido-k2N1,N5}cuprate(II)Formula 2a:Trisodium {1-(2-carboxylato-kO-5-sulfonatophenyl)-5-[3-(4,6-difluoropyrimidin-2-ylamino)-2-olato-kO-5-sulfonatophenyl]-3-phenylformazan-5-ido-k2N1,N5}cuprate(II) |
|
Notified classification and labelling according to CLP criteria
Acute Tox. 4 |
H302
|
H302
|
|
GHS07 GHS05 Dgr
|
|
|
|
|
4 |
|
View details
|
Eye Dam. 1 |
H318
|
H318
|
Eye Dam. 1 |
H318
|
H318
|
|
GHS05 Dgr
|
|
|
|
|
2 |
|
View details
|
Acute Tox. 4 |
H302
|
H302
|
|
GHS07 GHS05 Dgr
|
|
|
|
|
37 |
|
View details
|
Eye Dam. 1 |
H318
|
H318
|
Number of Aggregated Notifications: 3